Henry Schein Stock in Brief

Henry Schein logged a -2.2% change during today's afternoon session, and is now trading at a price of $79.04 per share. The S&P 500 index moved 0.59% and the Nasdaq posted a 1.00% change.

Henry Schein shares moved -7.44% over the last 52 weeks, with a high of $92.68 and a low of $64.75. During this time, the stock outperformed the S&P 500 index by 1.79%. As of January 2022, the company's 50-day average price is $83.0. Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries. The large-cap Consumer Cyclical company is based in Melville, NY.

The Company Has a Steady Stream of Positive Cash Flows:

2019-12-31 2020-12-31 2021-12-31 2022-12-31
Revenue (MM) $10,185 $10,080 $12,383 $12,603
Revenue Growth n/a -1.03% 22.85% 1.78%
Gross Margins 30.35% 27.92% 29.67% 30.4%
Gross Margins Growth n/a -8.01% 6.27% 2.46%
Operating Margins 7.05% 5.31% 6.88% 5.93%
Operating Margins Growth n/a -24.68% 29.57% -13.81%
Earnings Per Share $4.85 $2.83 $4.6 $4.08
EPS Growth n/a -41.65% 62.54% -11.3%
Free Cash Flow (MM) $578 $550 $631 $506
FCF Growth n/a -4.81% 14.71% -19.81%
Capital Expenditures (MM) $76 $49 $79 $96
Net Debt / EBITDA 0.53 0.25 0.76 1.1

Henry Schein Is Fairly Priced at Current Levels:

Compared to the Consumer Cyclical sector's average of 22.33, Henry Schein has a trailing twelve month P/E ratio of 20.37 and, according to its EPS guidance of 5.67, an expected P/E ratio of None.

The market is giving Henry Schein a fair value in terms of its book value, since its P/B ratio of 3.122 is consistent with its sector average, which stands at 3.12. The company's shares are currently trading 63.34% above their fair value as expressed by Benjamin Graham's formula:

√(22.5 * 5-year average EPS * book value per share) = √(22.5 * 3.98 * 26.15) = $48.39

11 analysts are following Henry Schein and have set target prices ranging from $69.0 to $99.0 per share. On average, they have given the company a rating of hold. At the current price of $79.04, HSIC is trading -5.18% away from its average analyst target price of $83.36 per share, implying an analyst consensus of some upside potential for the stock.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.